Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Plexpress and Phalanx Launch OneTRAC™ Gene Expression Service

Published: Friday, June 29, 2012
Last Updated: Friday, June 29, 2012
Bookmark and Share
New service to offer integrated genetic biomarker discovery, selection, validation and analysis.

Plexpress Oy and Phalanx Biotech Group have established a strategic alliance to offer the OneTRAC™ service.

The new service package will allow researchers to not only discover and select genomic biomarkers, but also to fully validate and understand their function in a streamlined, integrated workflow.

The OneTRAC™ analysis service will be offered by Plexpress in Europe, and by Phalanx Biotech in the United States and Asia.

Announcing the launch of the OneTRAC™ service at the 48th EUROTOX Congress, Jari Rautio, Ph.D., CEO of Plexpress commented: “By combining the coverage breadth of OneArray® microarrays and the high-throughput, multiplex capabilities of TRAC, OneTRAC™ offers researchers in industry and academia an integrated approach towards identifying, selecting and validating a robust set of gene expression signatures.”

Vivien Mak, Ph.D., Phalanx Biotech’s President, further supported the significance of the OneTRAC™ solution, “With continued interest among drug sponsors to supplement US regulatory submissions with toxicogenomic data, we believe the flexibility and scalability of OneTRAC™ will be well-received by customers investigating expression profiling at both the genome-wide and focused-gene levels. Whether it’s ADME-tox biomarkers or drug-response gene sets for pre-clinical and clinical development, OneTRAC™ is fully capable of addressing the diverse needs of genomic scientists.”

In the OneTRAC™ workflow, genome-wide expression patterns for mRNAs and microRNAs are profiled using Phalanx Biotech’s OneArray® microarrays to determine genes of interest and infer gene expression relationships.

Once biomarker signatures are identified, the target genes are validated and further investigated using Plexpress’ FAST TRAC gene expression analysis platform.

With the integrated OneTRAC™ service, researchers can easily scale the number of profiled samples across multiple conditions and transition effectively from discovery research to understanding biological function.

Besides its application in biomarker development, the OneTRAC™ service is suitable across a range of drug development and life sciences applications, and in several other model systems, including rat and mouse species.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Plexpress Announces Collaboration with Admescope
CRO to offer TRAC gene expression analysis for pre-clinical ADME-Tox studies.
Thursday, May 17, 2012
Plexpress and SBW Partner to Offer TRAC Gene Expression Analysis
CRO adds TRAC to service portfolio for pre-clinical ADME-Tox studies.
Tuesday, May 08, 2012
Plexpress Secures $2.3M to Commercialize TRAC High-Content Gene Expression Analysis Platform
Company targets applications including companion diagnostics and ADMET.
Thursday, April 19, 2012
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!